The incidence of POLE/POLD1 mutations among the overall CRC population has been reported to be 5–6% in various cohort studies, suggesting that patients with YO-CRC may have higher rates of POLE/POLD1 mutations [27,28]. The gene discussed is POLE; the disease is colorectal carcinoma.